Sharecare (SHCR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Sharecare Revenue Highlights


Latest Revenue (Y)

$445.25M

Latest Revenue (Q)

$94.27M

Main Segment (Y)

Enterprise

Sharecare Revenue by Period


Sharecare Revenue by Year

DateRevenueChange
2023-12-31$445.25M0.64%
2022-12-31$442.42M7.17%
2021-12-31$412.81M25.55%
2020-12-31$328.81M-3.16%
2019-12-31$339.54M-

Sharecare generated $445.25M in revenue during NA 2023, up 0.64% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Sharecare Revenue by Quarter

DateRevenueChange
2024-06-30$94.27M3.75%
2024-03-31$90.86M-13.69%
2023-12-31$105.28M-7.10%
2023-09-30$113.33M2.69%
2023-06-30$110.35M-5.11%
2023-03-31$116.30M-5.65%
2022-12-31$123.26M7.54%
2022-09-30$114.62M10.40%
2022-06-30$103.82M3.09%
2022-03-31$100.71M-15.04%
2021-12-31$118.54M12.23%
2021-09-30$105.62M7.27%
2021-06-30$98.46M9.15%
2021-03-31$90.20M2.02%
2020-12-31$88.41M10.19%
2020-09-30$80.24M2.57%
2020-06-30$78.23M-4.52%
2020-03-31$81.93M-10.33%
2019-12-31$91.36M-

Sharecare generated $94.27M in revenue during Q2 2024, up 3.75% compared to the previous quarter, and up 81.06% compared to the same period a year ago.

Sharecare Revenue Breakdown


Sharecare Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Enterprise$243.94M$258.64M$243.40M
Provider$119.34M$104.17M$90.92M
Life Sciences$81.97M$79.60M$78.49M

Sharecare's latest annual revenue breakdown by segment (product or service), as of Dec 23: Enterprise (54.79%), Provider (26.80%), and Life Sciences (18.41%).

Quarterly Revenue by Product

Product/ServiceDec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Provider$28.20M$32.98M$29.19M$28.97M$24.34M$28.71M$26.40M$24.72M$24.66M$24.11M
Enterprise$49.48M$60.22M$64.05M$70.19M$73.76M$65.22M$59.89M$59.77M$67.02M$62.84M
Life Sciences$27.59M$20.13M$17.11M$17.13M$25.16M$20.68M$17.53M$16.22M--
Consumer---------$18.67M

Sharecare's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Enterprise (47.00%), Provider (26.79%), and Life Sciences (26.21%).

Sharecare Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
EVHEvolent Health$1.96B$647.14M
PRVAPrivia Health Group$1.66B$422.33M
HQYHealthEquity$999.59M$287.60M
SHCRSharecare$445.25M$94.27M
CPSITruBridge$326.65M$82.71M
HCATHealth Catalyst$295.94M$74.72M
HSTMHealthStream$279.06M$71.56M
DHDefinitive Healthcare$251.41M$63.70M
NRCNational Research$148.58M$35.31M
STRMStreamline Health Solutions$22.60M$4.33M
FORAForian$20.48M$4.78M

SHCR Revenue FAQ


Sharecare's yearly revenue for 2023 was $445.25M, representing an increase of 0.64% compared to 2022. The company's yearly revenue for 2022 was $442.42M, representing an increase of 7.17% compared to 2021. SHCR's yearly revenue for 2021 was $412.82M, representing an increase of 25.55% compared to 2020.

Sharecare's quarterly revenue for Q2 2024 was $94.26M, a 3.75% increase from the previous quarter (Q1 2024), and a -14.58% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $90.86M, a -13.69% decrease from the previous quarter (Q4 2023), and a -21.87% decrease year-over-year (Q1 2023). SHCR's quarterly revenue for Q4 2023 was $105.28M, a -7.10% decrease from the previous quarter (Q3 2023), and a -14.59% decrease year-over-year (Q4 2022).

Sharecare's revenue growth rate for the last 3 years (2021-2023) was 7.86%, and for the last 5 years (2019-2023) was 31.13%.

Sharecare's revenue streams in c 23 are Enterprise, Provider, and Life Sciences. Enterprise generated $243.94M in revenue, accounting 54.79% of the company's total revenue, down -5.68% year-over-year. Provider generated $119.34M in revenue, accounting 26.80% of the company's total revenue, up 14.57% year-over-year. Life Sciences generated $81.97M in revenue, accounting 18.41% of the company's total revenue, up 2.97% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Sharecare was Enterprise. This segment made a revenue of $243.94M, representing 54.79% of the company's total revenue.